Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 22Genitourinary 13Gastrointestinal 4Breast 4Sarcoma 2Thoracic 1Other 1

Conditions

Breast Neoplasms 4Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 260Paclitaxel 216Cyclophosphamide 173Docetaxel 146Letrozole 126Fulvestrant 121Capecitabine 121Doxorubicin 111Carboplatin 98Bevacizumab 90exemestane 88Anastrozole 85Tamoxifen 77Lapatinib 77pembrolizumab 68Albumin-Bound Paclitaxel 67pertuzumab 62palbociclib 60Taxes 59Gemcitabine 57eribulin 48130-nm albumin-bound paclitaxel 47Radiotherapy 46Everolimus 44Ado-Trastuzumab Emtansine 43Vinorelbine 39ixabepilone 32Epirubicin 30Cisplatin 30pegfilgrastim 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Brachytherapy × Breast × Clear all
NCT01017549 2020-08-13

Post Market Study Using the Xoft Axxent System

Xoft, Inc.

Phase NA Completed
44 enrolled 5 charts
Breast

Breast Neoplasms, Neoplasms

NCT00214149 2018-11-05

Multi-catheter High Dose Rate (HDR) Breast Brachytherapy

University of Wisconsin, Madison

Phase 2 Terminated
127 enrolled 5 charts
Breast

Breast Neoplasms

NCT00290654 2017-12-28

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
45 enrolled 11 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00593346 2015-06-29

Evaluation of Accelerated Partial Breast Brachytherapy

Washington University School of Medicine

Phase NA Completed
151 enrolled 20 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡